Tag Archives: Pharmaceutical Executive

Drugs, Devices or Data – Which is more valuable?

A few months ago we blogged about how so many state-level governments are adopting legislation limiting or mandating disclosure of payments to physicians. This spend compliance is now top of mind for many pharmaceutical and medical device companies.

With their physician data spread across the enterprise among accounts payable, expense reporting, ERP, and CTMS systems, it is no wonder that many companies are struggling to conform to the ever stricter reporting requirements differing from state to state.

Not surprisingly, many are turning to Master Data Management as a way of gaining a unified view of physician data across these disparate sources. Many are also discovering that multidomain MDM solutions not only improve compliance but lead to increased sales. Through a single MDM hub they are now able to manage and track critical product master data elements, such as drugs, devices in addition to physician data, and the added quality, accuracy and relationships they uncover has allowed them to optimize and improve their business processes and resulting sales.

This intriguing topic certainly deserves more attention than our simple blog post. Which is why we are delighted to say that on September 24th, there will be a webinar panel moderated by William Looney of Pharmaceutical Executive magazine. Featured panelists will include:
• Hussain A. Mooraj, Vice President, Healthcare & Life Sciences, AMR Research, Inc.
• Anurag Wadehra, Sr. Vice President of Marketing & Product Management, Siperian
• Dan Goldsmith, Partner, IBM GBS
• David J. Eiben, Director, Business IS Consulting – PM Compliance, Boehringer Ingelheim Pharmaceuticals, Inc.

The event is free and anyone can register at www.Pharmexec.com/valuable.

FacebookTwitterLinkedInEmailPrintShare
Posted in Master Data Management | Tagged , , , , , , , , , , , , , , | 1 Comment